GeneMatrix Inc. (KOSDAQ:109820)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Drug Development, etc.	3.64B	3.86B	3.83B	4.11B	4.01B
Drug Development, etc. Growth	-5.63%	0.77%	-6.91%	2.52%	-8.25%
Diagnostic Reagent	3.32B	4.00B	4.13B	3.96B	5.20B
Diagnostic Reagent Growth	-17.09%	-3.15%	4.20%	-23.71%	-4.77%
Internal Revenue	-2.22B	-2.67B	-2.88B	-2.76B	-2.53B
Total	4.73B	5.19B	5.08B	5.32B	6.68B
Total Growth	-8.75%	2.15%	-4.43%	-20.39%	-8.43%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
South Korea	4.67B	-	-	-	-
Total	4.67B	-	-	-	-

Source: S&P Global Market Intelligence.